Skip to main content

Valsartan and Hydrochlorothiazide

NDC 33342-076 · Macleods Pharmaceuticals Limited

Generic nameValsartan and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)VALSARTAN, HYDROCHLOROTHIAZIDE
Strength25; 160 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

33342-076-10 — 90 TABLET in 1 BOTTLE (33342-076-10)

33342-076-15 — 500 TABLET in 1 BOTTLE (33342-076-15)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-051 — Losartan potassium and Hydrochlorothiazide, 33342-052 — Losartan potassium and Hydrochlorothiazide, 33342-057 — Irbesartan and Hydrochlorothiazide, 33342-058 — Irbesartan and Hydrochlorothiazide, 33342-062 — Valsartan, 33342-063 — Valsartan, 33342-064 — Valsartan, 33342-065 — Valsartan, 33342-074 — Valsartan and Hydrochlorothiazide, 33342-075 — Valsartan and Hydrochlorothiazide, 33342-077 — Valsartan and Hydrochlorothiazide, 33342-078 — Valsartan and Hydrochlorothiazide, 33342-131 — Candesartan Cilexetil and Hydrochlorothiazide, 33342-132 — Candesartan Cilexetil and Hydrochlorothiazide, 33342-133 — Candesartan Cilexetil and Hydrochlorothiazide, 33342-173 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-174 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-175 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-243 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-244 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, +1132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels